
Carlos Rodón Is Not Enough to Improve Yankees' World Series Hopes amid MLB Rumors
The New York Yankees entered the offseason with one goal in mind beyond re-signing Aaron Judge and keeping him in pinstripes forever: bolster a bullpen that was obliterated by the Houston Astros in the ALCS.
They appear poised to do that in the form of an offer to San Francisco Giants lefty Carlos Rodón, per Jon Heyman of The New York Post.
It would mark the second time the Yankees have been in a battle with the Giants over a free agent, the first being the aforementioned Judge. Is it worth getting into a front-office battle with the across-country team over a lefty with just two distinct pitches?
TOP NEWS

Assessing Every MLB Team's Development System ⚾
.png)
10 Scorching MLB Takes 🌶️

Yankees Call Up 6'7" Prospect 📈
The short answer: is yes, but the Yankees should know that Rodón is not the solution to the problem.
Pitching Depth, Injury History
The Yankees bullpen gave up a combined ERA of 3.97 per game, 30 hits and 18 runs, 15 of which were earned. Yankees pitchers were roughed up by Houston's offense en route to a nine-run differential across the four-game series.
Rodon had a very good 2022, going 14-8 with a 2.88 ERA while striking out 237 hitters and establishing a 1.03 WHIP. All while leaning on the fastball and slider, proving variance in pitching is not necessary if you can do two things very well.
In a marketplace set by the monstrous deals for Justin Verlander and Jacob deGrom, he is going to do very well financially, perhaps even with the Yankees. But it will not be the solution to New York's problems.
The team ranked fourth in innings pitch in 2022, according to MLB.com, with 79.2. Gerritt Cole (200.2), Nestor Cortes (158.1) and Jameson Taillon (177.1) were well north of 150 innings themselves.
Rodón is already 30 years old and has an injury history. He underwent Tommy John surgery in 2019 and even before that, had a history of arm fatigue earlier in his career. As late as 2021, there were very real questions about his future in the Majors.
Add that to an already exhausted bullpen with an innings and strikeouts deficiency to boot, and a $30 million AAV and there is reason to be cautious on the Yankees part. Especially considering they rank second in overall payroll and will be subject to a Competitive Balance Tax.
There are other pitchers, such as Chris Bassitt, Nathan Eovaldi and Noah Syndergaard, available who could be acquired to do the same thing for a more sensible financial burden. Bassitt turned down a $19 million option to remain with the Mets, but the Yankees would be able to acquire him for far less than the AAV Rodón is expected to demand.
Ditto Syndergaard, who can likely be acquired on a shorter, more cost prohibitive deal if his 2022 deal with the Angels is any indication.
The Yankees are not so far into the offseason and free agency that it cannot acquire multiple pieces to help strengthen its rotation rather than riskily overspending for Rodón without a guarantee of a World Series berth.
This is one instance where playing the waiting game and not jumping at the first big-name free agent at a position of need should benefit the Yankees in the long run.



.jpg)







